Koselugo 7.5 MG Oral Granules

RxCUI
2723661
RxNorm name
Koselugo 7.5 MG Oral Granules
Display name
Koselugo 7.5 MG Oral Granules
Full name
Koselugo 7.5 MG Oral Granules
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:05

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
KOSELUGOSELUMETINIBAstraZeneca Pharmaceuticals LP7d042c61-f28f-4ab5-ab10-d7558c0d49ff2026-05-26Warnings, Adverse reactionsExact identifier
rxcui: 2723661

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
7d042c61-f28f-4ab5-ab10-d7558c0d49ffKoselugo 7.5 MG Oral GranulesSY17These highlights do not include all the information needed to use KOSELUGO safely and effectively. See full prescribing information for KOSELUGO. KOSELUGO ® (selumetinib) capsules, for oral use KOSELUGO ® (selumetinib) oral granules Initial U.S. Approval: 202020260526
7d042c61-f28f-4ab5-ab10-d7558c0d49ffselumetinib 7.5 MG Oral Granules [Koselugo]SBD17These highlights do not include all the information needed to use KOSELUGO safely and effectively. See full prescribing information for KOSELUGO. KOSELUGO ® (selumetinib) capsules, for oral use KOSELUGO ® (selumetinib) oral granules Initial U.S. Approval: 202020260526
7d042c61-f28f-4ab5-ab10-d7558c0d49ffKoselugo 7.5 MG Oral GranulesPSN17These highlights do not include all the information needed to use KOSELUGO safely and effectively. See full prescribing information for KOSELUGO. KOSELUGO ® (selumetinib) capsules, for oral use KOSELUGO ® (selumetinib) oral granules Initial U.S. Approval: 202020260526